BCHE and nervous system disorder: Based on the obtained in silico, experimental and computational results on biological activity in the present work, novel carbamates 1–13 represent potential selective BChE inhibitors as new therapeutics for neurological disorders, and they can be incorporated into the chemical libraries used in high-throughput screening and drug development.